Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 538969Generated: October 31, 2026

Hydrochloric Acid → 2-Cyanophenylboronic acid

https://huagongshe.com/reaction/538969

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantBenzonitrileHCID 7505—
Reactant2,2,6,6-TetramethylpiperidineHCID 13035—
ReactantTriisopropyl borateHCID 21531—
ReactantButyllithiumHCID 178418339—
ReactantHCID 178418821HCID 178418821—
SolventTetrahydrofuranHCID 8028—
SolventHexaneHCID 8058—
SolventEthyl AcetateHCID 8857—
Product2-Cyanophenylboronic acidHCID 273461034%

Reaction Conditions

Temperature-78 °C

Reaction Steps

In a 300 ml nitrogen-substituted flask, 21.6 g (0.153 mol) of 2,2,6,6-tetramethylpiperidine was dissolved in 130 ml of THF. Then, to the resulting solution, 96 ml (0.153 mol) of a 15% solution of n-butyllithium in hexane was added dropwise at −10° C. to prepare lithium 2,2,6,6-tetramethylpiperidide. This solution was cooled to −78° C., and then 67 ml (0.291 mol) of triisopropoxyborane was added dropwise thereto. Next, 15 g (0.146 mol) of benzonitrile was added dropwise, and then the resulting solution was aged for 2 hours at the same temperature. The temperature of the reaction solution was increased to room temperature, and then the solution was hydrolyzed by 225 ml of 2N HCl. The solution was charged with 150 ml of ethyl acetate and stirred, and then the acid phase (pH<1) was separated. The aqueous phase was extracted with 105 ml of ethyl acetate. Then, the two organic phases were mixed and washed with 90 ml of saturated brine. The resulting organic phase was then dried with anhydrous magnesium sulfate and concentrated using an evaporator. The concentrated solution was charged with 100 ml of dichloromethane, and then the solution was charged with 50 ml of hexane at 0° C. The precipitated crystals were filtered and dried to obtain 7.3 g of 2-cyanophenylboronic acid crystals. The purity of the 2-cyanophenylboronic acid was 98.7%, in which 0.3 mol % of 1-phenyl-1-(2,2,6,6-tetramethylpiperidin-1-yl)methyl imine was included.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08865942B2
Source datasetuspto-grants-2014_10
ORD IDord-230ebfd2c82f4fd9a011878fb2358f04
Source noteuspto-grants-2014_10